Patent · US Expired

Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors

US7429598B2 · kind B2 · utility

8Cited by
3References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2003
Grant dateSep 30, 2008
Priority date
Expiry dateSep 17, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I)wherein R1, R2 and m are as defined in the description, their use as medicament, pharmaceutical compositions containing them and a process for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.